Ciaglia Tania, Miranda Maria Rosaria, Di Micco Simone, Vietri Mariapia, Smaldone Gerardina, Musella Simona, Di Sarno Veronica, Auriemma Giulia, Sardo Carla, Moltedo Ornella, Pepe Giacomo, Bifulco Giuseppe, Ostacolo Carmine, Campiglia Pietro, Manfra Michele, Vestuto Vincenzo, Bertamino Alessia
Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy.
NBFC-National Biodiversity Future Center, 90133 Palermo, Italy.
Antioxidants (Basel). 2024 Dec 23;13(12):1585. doi: 10.3390/antiox13121585.
Based on the established neuroprotective properties of indole-based compounds and their significant potential as multi-targeted therapeutic agents, a series of synthetic indole-phenolic compounds was evaluated as multifunctional neuroprotectors. Each compound demonstrated metal-chelating properties, particularly in sequestering copper ions, with quantitative analysis revealing approximately 40% chelating activity across all the compounds. In cellular models, these hybrid compounds exhibited strong antioxidant and cytoprotective effects, countering reactive oxygen species (ROS) generated by the Aβ(25-35) peptide and its oxidative byproduct, hydrogen peroxide, as demonstrated by quantitative analysis showing on average a 25% increase in cell viability and a reduction in ROS levels to basal states. Further analysis using thioflavin T fluorescence assays, circular dichroism, and computational studies indicated that the synthesized derivatives effectively promoted the self-disaggregation of the Aβ(25-35) fragment. Taken together, these findings suggest a unique profile of neuroprotective actions for indole-phenolic derivatives, combining chelating, antioxidant, and anti-aggregation properties, which position them as promising compounds for the development of multifunctional agents in Alzheimer's disease therapy. The methods used provide reliable in vitro data, although further in vivo validation and assessment of blood-brain barrier penetration are needed to confirm therapeutic efficacy and safety.
基于吲哚类化合物已确立的神经保护特性及其作为多靶点治疗剂的巨大潜力,一系列合成吲哚酚类化合物被评估为多功能神经保护剂。每种化合物都表现出金属螯合特性,特别是在螯合铜离子方面,定量分析显示所有化合物的螯合活性约为40%。在细胞模型中,这些杂合化合物表现出强大的抗氧化和细胞保护作用,可对抗由Aβ(25 - 35)肽及其氧化副产物过氧化氢产生的活性氧(ROS),定量分析表明,细胞活力平均增加25%,ROS水平降至基础状态。使用硫黄素T荧光测定、圆二色性和计算研究的进一步分析表明,合成衍生物有效地促进了Aβ(25 - 35)片段的自解聚。综上所述,这些发现表明吲哚酚衍生物具有独特的神经保护作用,兼具螯合、抗氧化和抗聚集特性,使其成为阿尔茨海默病治疗中开发多功能药物的有前景的化合物。尽管需要进一步的体内验证和血脑屏障穿透评估来确认治疗效果和安全性,但所使用的方法提供了可靠的体外数据。